|
Possible benefit:
|
No benefit is expected for patients
enrolling in the study. It is hoped that results from this study may
help future patients having lung surgery |
|
Purpose of trial:
|
The study will investigate the efficacy
of a new bipolar sealing forceps in cutting and sealing lung tissue
during surgery |
|
Drug/Device being tested:
|
TissueLink bipolar forceps |
|
Sponsoring Department:
|
Surgery |
|
SIU Faculty Physician:
|
Stephen
R. Hazelrigg, M.D., Theresa Boley,
R.N., M.S.N., A.P.N./F.N.P. |
|
Sponsoring Company:
|
TissueLink Medical, Inc. |
|
Number of other sites in trial:
|
One |
|
Type of patients needed:
|
Patients requiring a wedge resection
(partial removal of their lung) or lobectomy (removal of a lobe of
the lung) |
|
Age:
|
18 years and older |
|
Health status:
|
Patients should be medically fit to
undergo wedge resection or lobectomy of the lung |
|
Number of visits required:
|
Patients will be assessed before surgery
and 10 days after the surgery |
|
Length of study involvement:
|
Approximately two weeks |
|
Tests to be performed:
|
Routine tests associated with assessment
for wedge resection or lobectomy are performed including a chest radiograph
(CXR), CT scan and serum analysis. The study does not require additional
tests. Patients are monitored to determine length of postoperative
air leak and amount of postoperative chest drainage |
|
Contact Person:
|
Theresa Boley, R.N., M.S.N., A.P.N./F.N.P.,
217-545-5000, E-Mail Address: tboley@siumed.edu |
